Kambarajapuram Desikan, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
Dr. Kambarajapuram Desikan is a medical oncologist from Little Rock, Arkansas and he works at White River Medical Center. He got his diploma from Madras Medical College and did a fellowship in Medical Oncology at the top University of Arkansas for Medical Sciences and one in Hematology at St Elizabeth's Medical Center. The doctor is certified in Hematology, Internal Medicine, Medical Oncology and has an experience of more than 20 years.
Madras Medical College
Medical School
St Elizabeth's Medical Center
Fellowship
University of Arkansas for Medical Sciences
Fellowship
American Board of Internal Medicine - Oncology
AR State Medical License: Active through 2013
American Board of Internal Medicine: Hematology
American Board of Internal Medicine: Medical Oncology
American Board of Internal Medicine: Internal Medicine
382 citations A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma.
Richardson, P. G., Blood, E., Mitsiades, C. S., Jagannath, S., Zeldenrust, S. R., Alsina, M., Schlossman, R. L., Rajkumar, S. V., Desikan, K. R., Hideshima, T., Munshi...; Blood. 2006 Nov 15.
See more >>2 citations Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma.
Butch, A. W., Badros, A., Desikan, K. R., Munshi, N. C.; Bone Marrow Transplant. 2001 Mar.
See more >>Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone.
Desikan, K. R., Tricot, G., Munshi, N. C., Anaissie, E., Spoon, D., Fassas, A., Toor, A., Zangari, M., Badros, A., Morris, C., Vesole, D. H., Siegel, D., Jagannath, S....; Br J Haematol. 2001 Jan.
See more >>